Role of Cardiomyocyte Apoptosis in Heart Failure

2021 ◽  
pp. 253-267
Author(s):  
Sukhwinder K. Bhullar ◽  
Anureet K. Shah ◽  
Naranjan S. Dhalla
2008 ◽  
Vol 7 (3) ◽  
pp. 33-38
Author(s):  
A. P. Khlapov ◽  
Yu. Yu. Vechersky ◽  
N. V. Ryazantseva ◽  
V. V. Kalyuzhin ◽  
L. R. Mustafina ◽  
...  

Here the role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling was investigated. The samples of left ventricle were obtained on 50 patients with the diagnosed atherosclerotic disease of coronary arteries and heart failure. Obtained data allow to approve about the maximal importance of cardiomyocyte apoptosis at an early stages of ischemic myocardial remodeling. The role of cardiomyocyte apoptosis was decreased at a high volume of left ventricle. The received results suggest about an importance of cardiomyocyte apoptosis as an marker of ischemic myocardial remodeling and heart failure.


2019 ◽  
Vol 4 (9) ◽  

In the presented mini-review of the literature the role of cardiomyocyte apoptosis in the pathogenesis of neuroleptic cardiomyopathy is considered. Despite the insufficient development of the issue and the scarcity of literature data, various ways of negative influence on the heart of the side effect of cardiotoxic antipsychotic drugs leading to a decrease in myocardial mass due to the death of cardiomyocytes by apoptosis are convincingly shown, which initiates the process of heart remodeling with the subsequent development of myocardial dysfunction and progression of heart failure.


2016 ◽  
Vol 130 (23) ◽  
pp. 2139-2149 ◽  
Author(s):  
Idoia Gallego ◽  
Javier Beaumont ◽  
Begoña López ◽  
Susana Ravassa ◽  
Juan José Gómez-Doblas ◽  
...  

Myocardial miR-10b down-regulation may be involved in the increase in cardiomyocyte apoptosis in AS patients, probably through apoptosis protease-activating factor-1 (Apaf-1) regulation. In turn, increased cardiomyocyte apoptosis contributes to cardiomyocyte damage and heart failure (HF) development.


2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
A Haryono ◽  
K Ikeda ◽  
D B Nugroho ◽  
H Kitagawa ◽  
M Igarashi ◽  
...  

Abstract Background Cardiac extracellular matrix (ECM) is critically involved in cardiac homeostasis by providing mechanical support as well as modulating growth factor signaling. Cardiac ECM dysregulation has been shown in heart failure pathogenesis, and accumulation of chondroitin sulfate glycosaminoglycans (CS-GAGs) was previously shown to exacerbate heart failure by augmenting inflammation and fibrosis at the chronic phase. However, it remains unclear whether and the mechanism by which CS-GAGs cause cardiac dysfunction, especially at the acute phase. Purpose The purpose of this study is to elucidate the role of CS-GAGs in heart failure. Methods In this study, we analyzed the role of CS-GAGs in heart failure using mice with target deletion of chondroitin sulfate N-acetylgalactosaminyltransferase (ChGn)-2 that elongates CS chains of GAGs. Heart failure was induced by transverse aortic constriction (TAC) in mice. Since cardiac fibroblasts (CFs) are the primary cells for ECM production in the heart, we explored the role of CF-derived ECM in cardiomyocyte apoptosis. CFs were given stretch stimuli that mimic pressure overload conditions. Results Significant CS-GAGs accumulation was detected in the heart of WT mice after TAC, which was substantially reduced in the heart of ChGn2−/− mice. Unexpectedly, loss of ChGn-2 deteriorated left ventricular systolic dysfunction accompanied by augmented cardiac hypertrophy and increased cardiomyocyte apoptosis. Stretch stimuli increased ChGn-2 expression and enhanced GAG production in CFs. Interestingly, only conditioned medium (CM) derived from stretched CFs showed protective effects on cardiomyocyte death induced by doxorubicin. Degradation of CS-GAGs in CFs-derived CM by using Chondroitinase ABC abolished its cardioprotective effect. Further experiments revealed that this cardioprotective effect is at least partially through CS-GAGs-derived PI3K/AKT pathway activation via CD44. Conclusion Our data revealed that CF-derived GAGs protect cardiomyocytes from death in the acute phase of heart failure due to pressure overload; thus, insufficient GAGs production caused by loss of ChGn-2 exacerbated heart failure. FUNDunding Acknowledgement Type of funding sources: None.


2020 ◽  
Vol 134 (1) ◽  
pp. 71-72
Author(s):  
Naseer Ahmed ◽  
Masooma Naseem ◽  
Javeria Farooq

Abstract Recently, we have read with great interest the article published by Ibarrola et al. (Clin. Sci. (Lond.) (2018) 132, 1471–1485), which used proteomics and immunodetection methods to show that Galectin-3 (Gal-3) down-regulated the antioxidant peroxiredoxin-4 (Prx-4) in cardiac fibroblasts. Authors concluded that ‘antioxidant activity of Prx-4 had been identified as a protein down-regulated by Gal-3. Moreover, Gal-3 induced a decrease in total antioxidant capacity which resulted in a consequent increase in peroxide levels and oxidative stress markers in cardiac fibroblasts.’ We would like to point out some results stated in the article that need further investigation and more detailed discussion to clarify certain factors involved in the protective role of Prx-4 in heart failure.


Sign in / Sign up

Export Citation Format

Share Document